Allergan’s fourth-quarter revenues rose by 6.6 percent to $4,351million. The group posted an operating loss of $276.6 million for the period compared with an operating loss of $5,384 million a year earlier. On an adjusted basis, it booked an operating income of $2.079 million, up by 8.4 percent. Allergan expects ...
Buying a membership today will give you:
To continue reading this article register now.